Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)
PHASE3CompletedINTERVENTIONAL
Enrollment
54
Participants
Timeline
Start Date
May 31, 2003
Primary Completion Date
August 31, 2003
Study Completion Date
August 31, 2003
Conditions
Rhinitis, Allergic, SeasonalAsthma
Interventions
DRUG
Desloratadine
desloratadine syrup; 5.0 mL once daily for 28 days
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00805324 - Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472) | Biotech Hunter | Biotech Hunter